Take a pass on stocks like Kimberly-Clark or Pfizer that are bucking Wednesday's sell-off and going higher.
This sort of insider activity often coincides with a turnaround in these types of beaten down equities.
While markets are higher Tuesday, there is little to suggest recent choppy action won't continue.
The bounce this morning is producing a sigh of relief, but this is going to remain a difficult trading market.
I hold two broken stocks at the moment: GreenSky and Genprex.
These small cap stocks are selling significantly below the prices they debuted on the market.
It is all about perception, and here are strong names to pick up on market weakness.
BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.
Rite Aid CEO John Standley faces shareholders's scrutiny after the merger flop.
Let's review all our charts and indicators.